2003He huaxue yu fangshe huaxueRequires access

PREPARATION AND BIODISTRIBUTION OF ~(188)Re-TCTMP

Jiang Shu

Open publisher page 0 citations

Abstract

TCTMP(1,4,8,11tertraaza cyclotetradecyl1,4,8,11tetramethylene phosphonate) is synthesized and coupled with 188Re. The coupling condition,stability and biodistribution of 188ReTCTMP in mice are investigated. The results show that satisfactory complexation yield of 188Re could be obtained under condition of medium pH=2.0,0.8~1.6 mg of SnCl2 and 50 mg of ligand. The complex exhibits high stability and maintains its high complexation yield (95%) in 8 d without protection of N2. The results of biodistribution indicate considerably strong affinity of 188ReTCTMP to bone and very low nontarget tissue's uptake. The concentration of 188ReTCTMP in blood is (0.06±0.02)%/g at 6 h after injection,while the concentration of 188ReHEDP is (0.28±0.05) %/g at 6 h after injection,which might be due to the higher stability of 188ReTCTMP in vitro and in vivo. Comparing with 188ReHEDP,188ReTCTMP exhibits better potential for the treatment of metastases.

About this research paper

What this paper is about

TCTMP(1,4,8,11tertraaza cyclotetradecyl1,4,8,11tetramethylene phosphonate) is synthesized and coupled with 188Re. The coupling condition,stability and biodistribution of 188ReTCTMP in mice are investigated. The results show that satisfactory complexation yield of 188Re could be obtained under condition of medium pH=2.0,0.8~1.6 mg of SnCl2 and 50 mg of ligand. The complex exhibits high stability and maintains its high complexation yield (95%) in 8 d without protection of N2. The results of biodistribution indicate considerably strong affinity of 188ReTCTMP to bone and very low nontarget tissue's uptake. The concentration of 188ReTCTMP in blood is (0.06±0.02)%/g at 6 h after injection,while the concentration of 188ReHEDP is (0.28±0.05) %/g at 6 h after injection,which might be due to the higher stability of 188ReTCTMP in vitro and in vivo. Comparing with 188ReHEDP,188ReTCTMP exhibits better potential for the treatment of metastases.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

TCTMP(1,4,8,11tertraaza cyclotetradecyl1,4,8,11tetramethylene phosphonate) is synthesized and coupled with 188Re. The coupling condition,stability and biodistribution of 188ReTCTMP in mice are investigated. The results show that satisfactory complexation yield of 188Re could be obtained under condition of medium pH=2.0,0.8~1.6 mg of SnCl2 and 50 mg of ligand. The complex exhibits high stability and maintains its high complexation yield (95%) in 8 d without protection of N2. The results of biodistribution indicate considerably strong affinity of 188ReTCTMP to bone and very low nontarget tissue's uptake. The concentration of 188ReTCTMP in blood is (0.06±0.02)%/g at 6 h after injection,while the concentration of 188ReHEDP is (0.28±0.05) %/g at 6 h after injection,which might be due to the higher stability of 188ReTCTMP in vitro and in vivo. Comparing with 188ReHEDP,188ReTCTMP exhibits better potential for the treatment of metastases.

Key concepts: Biodistribution, Chemistry, Yield (engineering), Phosphonate, Ligand (biochemistry), In vivo, Nuclear chemistry, In vitro

Related papers

Back to paper searchBrowse research topicsOriginal source
PREPARATION AND BIODISTRIBUTION OF ~(188)Re-TCTMP — Research Paper | ScholarLens